17-alpha-Hydroxyprogesterone
The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Atomoxetine.
Abemaciclib
The metabolism of Abemaciclib can be decreased when combined with Atomoxetine.
Abiraterone
The serum concentration of Atomoxetine can be increased when it is combined with Abiraterone.
Advertisement
Acebutolol
Atomoxetine may increase the hypertensive activities of Acebutolol.
Acenocoumarol
The metabolism of Acenocoumarol can be decreased when combined with Atomoxetine.
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Atomoxetine.
Advertisement
Acetylcholine
The metabolism of Acetylcholine can be decreased when combined with Atomoxetine.
Acetylcholine Chloride
The metabolism of Acetylcholine can be decreased when combined with Atomoxetine.
Ado-Trastuzumab Emtansine
The metabolism of Trastuzumab emtansine can be decreased when combined with Atomoxetine.
Advertisement
Ajmaline
The metabolism of Ajmaline can be decreased when combined with Atomoxetine.
Albendazole
The metabolism of Albendazole can be decreased when combined with Atomoxetine.
Albuterol
Atomoxetine may increase the tachycardic activities of Salbutamol.
Alclometasone
The metabolism of Alclometasone can be decreased when combined with Atomoxetine.
Alfentanil
The metabolism of Alfentanil can be decreased when combined with Atomoxetine.
Alfuzosin
The metabolism of Alfuzosin can be decreased when combined with Atomoxetine.
Aliskiren
The metabolism of Aliskiren can be decreased when combined with Atomoxetine.
Allylestrenol
The metabolism of Allylestrenol can be decreased when combined with Atomoxetine.
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Atomoxetine.
Alogliptin
The metabolism of Alogliptin can be decreased when combined with Atomoxetine.
Alosetron
The metabolism of Alosetron can be decreased when combined with Atomoxetine.
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Atomoxetine.
Alprenolol
The metabolism of Alprenolol can be decreased when combined with Atomoxetine.
Ambrisentan
The metabolism of Ambrisentan can be decreased when combined with Atomoxetine.
Ambroxol
The metabolism of Ambroxol can be decreased when combined with Atomoxetine.
Aminophylline
The metabolism of Aminophylline can be decreased when combined with Atomoxetine.
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Atomoxetine.
Amiodarone
The serum concentration of Atomoxetine can be increased when it is combined with Amiodarone.
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Atomoxetine.
Amlodipine
The metabolism of Amlodipine can be decreased when combined with Atomoxetine.
Amoxapine
The metabolism of Amoxapine can be decreased when combined with Atomoxetine.
Amphetamine
Atomoxetine may increase the hypertensive activities of Amphetamine.
Amprenavir
The metabolism of Amprenavir can be decreased when combined with Atomoxetine.
Amsacrine
The metabolism of Amsacrine can be decreased when combined with Atomoxetine.
Anagrelide
Atomoxetine may increase the QTc-prolonging activities of Anagrelide.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Atomoxetine.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Atomoxetine.
Apalutamide
The serum concentration of Atomoxetine can be decreased when it is combined with Apalutamide.
Apixaban
The serum concentration of Apixaban can be increased when it is combined with Atomoxetine.
Apremilast
The metabolism of Apremilast can be decreased when combined with Atomoxetine.
Aprepitant
The metabolism of Aprepitant can be decreased when combined with Atomoxetine.
Aprindine
The metabolism of Aprindine can be decreased when combined with Atomoxetine.
Arbutamine
Atomoxetine may increase the tachycardic activities of Arbutamine.
Arformoterol
Atomoxetine may increase the tachycardic activities of Arformoterol.
Argatroban
The metabolism of Argatroban can be decreased when combined with Atomoxetine.
Argatroban Anhydrous
The metabolism of Argatroban can be decreased when combined with Atomoxetine.
Aripiprazole
The serum concentration of Aripiprazole can be increased when it is combined with Atomoxetine.
Armodafinil
The metabolism of Atomoxetine can be decreased when combined with Armodafinil.
Arsenic Trioxide
Atomoxetine may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Atomoxetine may increase the QTc-prolonging activities of Artemether.
Asenapine
Atomoxetine may increase the QTc-prolonging activities of Asenapine.
Astemizole
The metabolism of Astemizole can be decreased when combined with Atomoxetine.
Atazanavir
The metabolism of Atazanavir can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Atomoxetine is combined with Atorvastatin.
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Atomoxetine.
Axitinib
The metabolism of Axitinib can be decreased when combined with Atomoxetine.
Azelastine
The metabolism of Azelastine can be decreased when combined with Atomoxetine.
Azithromycin
The metabolism of Azithromycin can be decreased when combined with Atomoxetine.
Bambuterol
Atomoxetine may increase the tachycardic activities of Bambuterol.
Baricitinib
The metabolism of Baricitinib can be decreased when combined with Atomoxetine.
Bedaquiline
The metabolism of Bedaquiline can be decreased when combined with Atomoxetine.
Benzphetamine
Atomoxetine may increase the hypertensive activities of Benzphetamine.
Benztropine
The metabolism of Benzatropine can be decreased when combined with Atomoxetine.
Benzyl Alcohol
The metabolism of Benzyl alcohol can be decreased when combined with Atomoxetine.
Bepridil
The metabolism of Bepridil can be decreased when combined with Atomoxetine.
Betaxolol
The metabolism of Betaxolol can be decreased when combined with Atomoxetine.
Bexarotene
The metabolism of Bexarotene can be decreased when combined with Atomoxetine.
Bezafibrate
The metabolism of Bezafibrate can be decreased when combined with Atomoxetine.
Bicalutamide
The metabolism of Bicalutamide can be decreased when combined with Atomoxetine.
Bictegravir
The metabolism of Bictegravir can be decreased when combined with Atomoxetine.
Bisoprolol
The metabolism of Bisoprolol can be decreased when combined with Atomoxetine.
Boceprevir
The metabolism of Boceprevir can be decreased when combined with Atomoxetine.
Bortezomib
The metabolism of Bortezomib can be decreased when combined with Atomoxetine.
Bosentan
The serum concentration of Bosentan can be increased when it is combined with Atomoxetine.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Atomoxetine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Atomoxetine.
Brentuximab Vedotin
The metabolism of Brentuximab vedotin can be decreased when combined with Atomoxetine.
Brexpiprazole
The serum concentration of Brexpiprazole can be increased when it is combined with Atomoxetine.
Brigatinib
The metabolism of Brigatinib can be decreased when combined with Atomoxetine.
Brinzolamide
The metabolism of Brinzolamide can be decreased when combined with Atomoxetine.
Brivaracetam
The metabolism of Brivaracetam can be decreased when combined with Atomoxetine.
Bromazepam
The metabolism of Bromazepam can be decreased when combined with Atomoxetine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Atomoxetine.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Atomoxetine.
Budesonide
The serum concentration of Budesonide can be increased when it is combined with Atomoxetine.
Bupivacaine
The metabolism of Bupivacaine can be decreased when combined with Atomoxetine.
Buprenorphine
The metabolism of Buprenorphine can be decreased when combined with Atomoxetine.
Bupropion
The serum concentration of Atomoxetine can be increased when it is combined with Bupropion.
Buspirone
The metabolism of Buspirone can be decreased when combined with Atomoxetine.
Busulfan
The metabolism of Busulfan can be decreased when combined with Atomoxetine.
Cabazitaxel
The metabolism of Cabazitaxel can be decreased when combined with Atomoxetine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Atomoxetine.
Cabozantinib
The metabolism of Cabozantinib can be decreased when combined with Atomoxetine.
Caffeine
The metabolism of Caffeine can be decreased when combined with Atomoxetine.
Calcitriol
The metabolism of Calcitriol can be decreased when combined with Atomoxetine.
Canagliflozin
The metabolism of Canagliflozin can be decreased when combined with Atomoxetine.
Canagliflozin Anhydrous
The metabolism of Canagliflozin can be decreased when combined with Atomoxetine.
Cannabidiol
The metabolism of Cannabidiol can be decreased when combined with Atomoxetine.
Captopril
The metabolism of Captopril can be decreased when combined with Atomoxetine.
Carbamazepine
The metabolism of Atomoxetine can be increased when combined with Carbamazepine.
Carbinoxamine
The metabolism of Carbinoxamine can be decreased when combined with Atomoxetine.
Cariprazine
The metabolism of Cariprazine can be decreased when combined with Atomoxetine.
Carteolol
The metabolism of Carteolol can be decreased when combined with Atomoxetine.
Carvedilol
The metabolism of Carvedilol can be decreased when combined with Atomoxetine.
Celecoxib
The metabolism of Celecoxib can be decreased when combined with Atomoxetine.
Celiprolol
Atomoxetine may increase the hypertensive activities of Celiprolol.
Cephalexin
The metabolism of Cephalexin can be decreased when combined with Atomoxetine.
CEPHALEXIN ANHYDROUS
The metabolism of Cephalexin can be decreased when combined with Atomoxetine.
Ceritinib
Atomoxetine may increase the QTc-prolonging activities of Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Atomoxetine.
Cevimeline
The metabolism of Cevimeline can be decreased when combined with Atomoxetine.
Chenodeoxycholate
The metabolism of Chenodeoxycholic acid can be decreased when combined with Atomoxetine.
Chenodeoxycholic Acid
The metabolism of Chenodeoxycholic acid can be decreased when combined with Atomoxetine.
Chloramphenicol
The metabolism of Atomoxetine can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The metabolism of Chlordiazepoxide can be decreased when combined with Atomoxetine.
Chlormethiazole
The metabolism of clomethiazole can be decreased when combined with Atomoxetine.
Chloroquine
The metabolism of Chloroquine can be decreased when combined with Atomoxetine.
Chlorpheniramine
The metabolism of Chlorphenamine can be decreased when combined with Atomoxetine.
CHLORPHENIRAMINE POLISTIREX
The metabolism of Chlorphenamine can be decreased when combined with Atomoxetine.
Chlorpromazine
The metabolism of Chlorpromazine can be decreased when combined with Atomoxetine.
Chlorzoxazone
The metabolism of Chlorzoxazone can be decreased when combined with Atomoxetine.
Cholecalciferol
The metabolism of Cholecalciferol can be decreased when combined with Atomoxetine.
Ciclesonide
The metabolism of Ciclesonide can be decreased when combined with Atomoxetine.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Atomoxetine.
Cimetidine
The metabolism of Atomoxetine can be decreased when combined with Cimetidine.
Cinacalcet
The serum concentration of Atomoxetine can be increased when it is combined with Cinacalcet.
Cinnarizine
The metabolism of Cinnarizine can be decreased when combined with Atomoxetine.
Ciprofloxacin
Atomoxetine may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Atomoxetine may increase the QTc-prolonging activities of Cisapride.
Citalopram
Atomoxetine may increase the QTc-prolonging activities of Citalopram.
Clarithromycin
The metabolism of Clarithromycin can be decreased when combined with Atomoxetine.
Clemastine
The metabolism of Atomoxetine can be decreased when combined with Clemastine.
Clenbuterol
Atomoxetine may increase the hypertensive activities of Clenbuterol.
Clevidipine
The metabolism of Clevidipine can be decreased when combined with Atomoxetine.
Clevidipine butyrate
The metabolism of Clevidipine can be decreased when combined with Atomoxetine.
Clindamycin
The metabolism of Clindamycin can be decreased when combined with Atomoxetine.
Clobazam
The metabolism of Clobazam can be decreased when combined with Atomoxetine.
Clofazimine
The metabolism of Clofazimine can be decreased when combined with Atomoxetine.
Clofezone
The metabolism of Rabeprazole can be decreased when combined with Atomoxetine.
Clofibrate
The metabolism of Clofibrate can be decreased when combined with Atomoxetine.
Clomipramine
The metabolism of Clomipramine can be decreased when combined with Atomoxetine.
Clonazepam
The metabolism of Clonazepam can be decreased when combined with Atomoxetine.
Clonidine
The metabolism of Clonidine can be decreased when combined with Atomoxetine.
Clopidogrel
The metabolism of Clopidogrel can be decreased when combined with Atomoxetine.
Clorazepate
The metabolism of Clorazepate can be decreased when combined with Atomoxetine.
CLORAZEPIC ACID
The metabolism of Clorazepate can be decreased when combined with Atomoxetine.
Clotiazepam
The metabolism of Clotiazepam can be decreased when combined with Atomoxetine.
Clotrimazole
The metabolism of Atomoxetine can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Clozapine can be decreased when combined with Atomoxetine.
Cobicistat
The serum concentration of Atomoxetine can be increased when it is combined with Cobicistat.
Cobimetinib
The serum concentration of Cobimetinib can be increased when it is combined with Atomoxetine.
Cocaine
The serum concentration of Atomoxetine can be increased when it is combined with Cocaine.
Codeine
The therapeutic efficacy of Codeine can be decreased when used in combination with Atomoxetine.
Codeine Anhydrous
The therapeutic efficacy of Codeine can be decreased when used in combination with Atomoxetine.
CODEINE POLISTIREX
The therapeutic efficacy of Codeine can be decreased when used in combination with Atomoxetine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Atomoxetine.
Conivaptan
The metabolism of Conivaptan can be decreased when combined with Atomoxetine.
Copanlisib
The metabolism of Copanlisib can be decreased when combined with Atomoxetine.
Cortisone Acetate
The metabolism of Cortisone acetate can be decreased when combined with Atomoxetine.
Crizotinib
The metabolism of Crizotinib can be decreased when combined with Atomoxetine.
Cyclobenzaprine
The metabolism of Cyclobenzaprine can be decreased when combined with Atomoxetine.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Atomoxetine.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Atomoxetine.
Cyclosporine
The metabolism of Cyclosporine can be decreased when combined with Atomoxetine.
Cytarabine
The metabolism of Cytarabine can be decreased when combined with Atomoxetine.
Dabrafenib
The serum concentration of Atomoxetine can be decreased when it is combined with Dabrafenib.
Daclatasvir
The metabolism of Daclatasvir can be decreased when combined with Atomoxetine.
Dantrolene
The metabolism of Dantrolene can be decreased when combined with Atomoxetine.
Dapagliflozin
The metabolism of Dapagliflozin can be decreased when combined with Atomoxetine.
Dapsone
The metabolism of Dapsone can be decreased when combined with Atomoxetine.
Darifenacin
The metabolism of Darifenacin can be decreased when combined with Atomoxetine.
Darunavir
The serum concentration of Atomoxetine can be increased when it is combined with Darunavir.
Dasabuvir
The metabolism of Dasabuvir can be decreased when combined with Atomoxetine.
Dasatinib
The metabolism of Dasatinib can be decreased when combined with Atomoxetine.
Dasatinib Anhydrous
The metabolism of Dasatinib can be decreased when combined with Atomoxetine.
Daunorubicin
The metabolism of Daunorubicin can be decreased when combined with Atomoxetine.
Debrisoquin
The metabolism of Debrisoquin can be decreased when combined with Atomoxetine.
Deflazacort
The metabolism of Deflazacort can be decreased when combined with Atomoxetine.
Delavirdine
The serum concentration of Atomoxetine can be increased when it is combined with Delavirdine.
Desipramine
The metabolism of Desipramine can be decreased when combined with Atomoxetine.
Desvenlafaxine
The metabolism of Desvenlafaxine can be decreased when combined with Atomoxetine.
Deutetrabenazine
The metabolism of Deutetrabenazine can be decreased when combined with Atomoxetine.
Dexamethasone
The metabolism of Dexamethasone can be decreased when combined with Atomoxetine.
Dexchlorpheniramine maleate
The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Atomoxetine.
Dexfenfluramine
The metabolism of Dexfenfluramine can be decreased when combined with Atomoxetine.
Dexlansoprazole
The metabolism of Dexlansoprazole can be decreased when combined with Atomoxetine.
Dexmethylphenidate
The metabolism of Dexmethylphenidate can be decreased when combined with Atomoxetine.
Dextroamphetamine
The metabolism of Dextroamphetamine can be decreased when combined with Atomoxetine.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Atomoxetine.
Diazepam
The metabolism of Diazepam can be decreased when combined with Atomoxetine.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Atomoxetine.
Dienogest
The metabolism of Dienogest can be decreased when combined with Atomoxetine.
Digitoxin
The metabolism of Digitoxin can be decreased when combined with Atomoxetine.
Digoxin
The metabolism of Digoxin can be decreased when combined with Atomoxetine.
Dihydrocodeine
The metabolism of Dihydrocodeine can be decreased when combined with Atomoxetine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Atomoxetine.
Diltiazem
The metabolism of Diltiazem can be decreased when combined with Atomoxetine.
Diphenhydramine
The metabolism of Diphenhydramine can be decreased when combined with Atomoxetine.
Dipivefrin
Atomoxetine may increase the tachycardic activities of Dipivefrin.
Disopyramide
Atomoxetine may increase the QTc-prolonging activities of Disopyramide.
Disulfiram
The metabolism of Disulfiram can be decreased when combined with Atomoxetine.
Dobutamine
Atomoxetine may increase the hypertensive activities of Dobutamine.
Docetaxel
The metabolism of Docetaxel can be decreased when combined with Atomoxetine.
DOCETAXEL ANHYDROUS
The metabolism of Docetaxel can be decreased when combined with Atomoxetine.
Dofetilide
The serum concentration of Dofetilide can be increased when it is combined with Atomoxetine.
Dolasetron
The metabolism of Dolasetron can be decreased when combined with Atomoxetine.
Domperidone
The serum concentration of Domperidone can be increased when it is combined with Atomoxetine.
Donepezil
The metabolism of Donepezil can be decreased when combined with Atomoxetine.
Dopamine
Atomoxetine may increase the hypertensive activities of Dopamine.
Dorzolamide
The metabolism of Dorzolamide can be decreased when combined with Atomoxetine.
Dothiepin
The serum concentration of Atomoxetine can be increased when it is combined with Dosulepin.
Doxazosin
The metabolism of Doxazosin can be decreased when combined with Atomoxetine.
Doxepin
The metabolism of Doxepin can be decreased when combined with Atomoxetine.
Doxorubicin
The metabolism of Doxorubicin can be decreased when combined with Atomoxetine.
Doxorubicin Hydrochloride
The metabolism of Doxorubicin can be decreased when combined with Atomoxetine.
Dronedarone
Atomoxetine may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Atomoxetine may increase the QTc-prolonging activities of Droperidol.
Droxidopa
Atomoxetine may increase the tachycardic activities of Droxidopa.
Duloxetine
The metabolism of Duloxetine can be decreased when combined with Atomoxetine.
Dutasteride
The metabolism of Dutasteride can be decreased when combined with Atomoxetine.
Efavirenz
The metabolism of Efavirenz can be decreased when combined with Atomoxetine.
Elbasvir
The metabolism of Elbasvir can be decreased when combined with Atomoxetine.
Eletriptan
The serum concentration of Eletriptan can be increased when it is combined with Atomoxetine.
Eliglustat
The serum concentration of Eliglustat can be increased when it is combined with Atomoxetine.
Elvitegravir
The metabolism of Elvitegravir can be decreased when combined with Atomoxetine.
Enalapril
The metabolism of Enalapril can be decreased when combined with Atomoxetine.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Atomoxetine.
Encainide
The metabolism of Encainide can be decreased when combined with Atomoxetine.
Enzalutamide
The metabolism of Enzalutamide can be decreased when combined with Atomoxetine.
Ephedrine
Atomoxetine may increase the hypertensive activities of Ephedrine.
Epinastine
The metabolism of Epinastine can be decreased when combined with Atomoxetine.
Epinephrine
Atomoxetine may increase the hypertensive activities of Epinephrine.
Eplerenone
The serum concentration of Eplerenone can be increased when it is combined with Atomoxetine.
Ergocalciferol
The metabolism of Ergocalciferol can be decreased when combined with Atomoxetine.
ergoloid mesylates, USP
The metabolism of Ergoloid mesylate can be decreased when combined with Atomoxetine.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Atomoxetine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Atomoxetine.
Erlotinib
The metabolism of Erlotinib can be decreased when combined with Atomoxetine.
Erythromycin
The metabolism of Erythromycin can be decreased when combined with Atomoxetine.
Escitalopram
Atomoxetine may increase the QTc-prolonging activities of Escitalopram.
Eslicarbazepine Acetate
The metabolism of Atomoxetine can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Esomeprazole can be decreased when combined with Atomoxetine.
Estazolam
The metabolism of Estazolam can be decreased when combined with Atomoxetine.
Estradiol
The metabolism of Estradiol can be decreased when combined with Atomoxetine.
Estradiol 3-Benzoate
The metabolism of Estradiol benzoate can be decreased when combined with Atomoxetine.
Estradiol acetate
The metabolism of Estradiol acetate can be decreased when combined with Atomoxetine.
Estradiol Cypionate
The metabolism of Estradiol cypionate can be decreased when combined with Atomoxetine.
Estradiol Valerate
The metabolism of Estradiol valerate can be decreased when combined with Atomoxetine.
Estramustine
The metabolism of Estramustine can be decreased when combined with Atomoxetine.
Estrogens, Conjugated (USP)
The metabolism of Conjugated estrogens can be decreased when combined with Atomoxetine.
Estrogens, Esterified (USP)
The metabolism of Estrogens, esterified can be decreased when combined with Atomoxetine.
Estrone
The metabolism of Estrone can be decreased when combined with Atomoxetine.
Eszopiclone
The metabolism of Eszopiclone can be decreased when combined with Atomoxetine.
Ethanol
The metabolism of Ethanol can be decreased when combined with Atomoxetine.
Ethinyl Estradiol
The metabolism of Ethinyl Estradiol can be decreased when combined with Atomoxetine.
Ethosuximide
The metabolism of Ethosuximide can be decreased when combined with Atomoxetine.
Ethylmorphine
The metabolism of Ethylmorphine can be decreased when combined with Atomoxetine.
Etilefrine
Atomoxetine may increase the hypertensive activities of Etilefrine.
Etonogestrel
The metabolism of Etonogestrel can be decreased when combined with Atomoxetine.
Etoposide
The metabolism of Etoposide can be decreased when combined with Atomoxetine.
Etoricoxib
The metabolism of Etoricoxib can be decreased when combined with Atomoxetine.
Etravirine
The metabolism of Etravirine can be decreased when combined with Atomoxetine.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Atomoxetine.
Exemestane
The metabolism of Exemestane can be decreased when combined with Atomoxetine.
Famciclovir
The metabolism of Famciclovir can be decreased when combined with Atomoxetine.
Felbamate
The metabolism of Felbamate can be decreased when combined with Atomoxetine.
Felodipine
The metabolism of Felodipine can be decreased when combined with Atomoxetine.
Fenofibrate
The metabolism of Fenofibrate can be decreased when combined with Atomoxetine.
Fenoterol
Atomoxetine may increase the hypertensive activities of Fenoterol.
Fentanyl
The serum concentration of Fentanyl can be increased when it is combined with Atomoxetine.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Atomoxetine.
Finasteride
The metabolism of Finasteride can be decreased when combined with Atomoxetine.
Fingolimod
The metabolism of Fingolimod can be decreased when combined with Atomoxetine.
Flecainide
The metabolism of Flecainide can be decreased when combined with Atomoxetine.
Flibanserin
The risk or severity of adverse effects can be increased when Atomoxetine is combined with Flibanserin.
Fluconazole
The metabolism of Atomoxetine can be decreased when combined with Fluconazole.
Flunarizine
The metabolism of Flunarizine can be decreased when combined with Atomoxetine.
Flunisolide
The metabolism of Flunisolide can be decreased when combined with Atomoxetine.
Flunisolide Anhydrous (obsolete)
The metabolism of Flunisolide can be decreased when combined with Atomoxetine.
Flunitrazepam
The metabolism of Flunitrazepam can be decreased when combined with Atomoxetine.
Fluorometholone
The metabolism of Fluorometholone can be decreased when combined with Atomoxetine.
Fluoxetine
The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.
Flupenthixol
Atomoxetine may increase the QTc-prolonging activities of Flupentixol.
Fluphenazine
The metabolism of Fluphenazine can be decreased when combined with Atomoxetine.
Flurazepam
The metabolism of Flurazepam can be decreased when combined with Atomoxetine.
Flutamide
The metabolism of Flutamide can be decreased when combined with Atomoxetine.
Fluticasone Furoate
The metabolism of Fluticasone furoate can be decreased when combined with Atomoxetine.
Fluticasone propionate
The metabolism of Fluticasone propionate can be decreased when combined with Atomoxetine.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Atomoxetine.
Fluvoxamine
The metabolism of Atomoxetine can be decreased when combined with Fluvoxamine.
Formoterol
Atomoxetine may increase the tachycardic activities of Formoterol.
Fosamprenavir
The metabolism of Fosamprenavir can be decreased when combined with Atomoxetine.
Fosphenytoin
The metabolism of Atomoxetine can be increased when combined with Fosphenytoin.
Fulvestrant
The metabolism of Fulvestrant can be decreased when combined with Atomoxetine.
Furazolidone
Furazolidone may increase the central neurotoxic activities of Atomoxetine.
Gadobenate
Atomoxetine may increase the QTc-prolonging activities of Gadobenic acid.
Galantamine
The metabolism of Galantamine can be decreased when combined with Atomoxetine.
Gefitinib
The metabolism of Gefitinib can be decreased when combined with Atomoxetine.
Gemfibrozil
The metabolism of Atomoxetine can be decreased when combined with Gemfibrozil.
Gemifloxacin
Atomoxetine may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Atomoxetine may increase the QTc-prolonging activities of Gemifloxacin.
Glipizide
The metabolism of Glipizide can be decreased when combined with Atomoxetine.
Glyburide
The metabolism of Glyburide can be decreased when combined with Atomoxetine.
Goserelin
Atomoxetine may increase the QTc-prolonging activities of Goserelin.
Granisetron
The metabolism of Granisetron can be decreased when combined with Atomoxetine.
Grazoprevir
The metabolism of Grazoprevir can be decreased when combined with Atomoxetine.
Grazoprevir anhydrous
The metabolism of Grazoprevir can be decreased when combined with Atomoxetine.
Grepafloxacin
The metabolism of Grepafloxacin can be decreased when combined with Atomoxetine.
Guanfacine
The metabolism of Guanfacine can be decreased when combined with Atomoxetine.
Halofantrine
The serum concentration of Halofantrine can be increased when it is combined with Atomoxetine.
Haloperidol
The metabolism of Haloperidol can be decreased when combined with Atomoxetine.
Halothane
The metabolism of Halothane can be decreased when combined with Atomoxetine.
Hexobarbital
The metabolism of Hexobarbital can be decreased when combined with Atomoxetine.
Histamine
The metabolism of Histamine can be decreased when combined with Atomoxetine.
Hydrocodone
The serum concentration of Hydrocodone can be increased when it is combined with Atomoxetine.
HYDROCODONE POLISTIREX
The serum concentration of Hydrocodone can be increased when it is combined with Atomoxetine.
Hydrocortisone
The metabolism of Hydrocortisone can be decreased when combined with Atomoxetine.
Hydromorphone
The metabolism of Hydromorphone can be decreased when combined with Atomoxetine.
hydroxyprogesterone caproate (USP)
The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Atomoxetine.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Atomoxetine.
Ibutilide
Atomoxetine may increase the QTc-prolonging activities of Ibutilide.
Idarubicin
The metabolism of Idarubicin can be decreased when combined with Atomoxetine.
Ifosfamide
The serum concentration of the active metabolites of Ifosfamide can be reduced when Ifosfamide is used in combination with Atomoxetine resulting in a loss in efficacy.
Iloperidone
Atomoxetine may increase the QTc-prolonging activities of Iloperidone.
Imatinib
The serum concentration of Imatinib can be increased when it is combined with Atomoxetine.
Imipramine
The metabolism of Imipramine can be decreased when combined with Atomoxetine.
Imiquimod
The metabolism of Imiquimod can be decreased when combined with Atomoxetine.
Indacaterol
Atomoxetine may increase the tachycardic activities of Indacaterol.
Indapamide
The metabolism of Indapamide can be decreased when combined with Atomoxetine.
Indinavir
The metabolism of Indinavir can be decreased when combined with Atomoxetine.
INDINAVIR ANHYDROUS
The metabolism of Indinavir can be decreased when combined with Atomoxetine.
Ipratropium Bromide
The metabolism of Ipratropium bromide can be decreased when combined with Atomoxetine.
Ipratropium Bromide Anhydrous
The metabolism of Ipratropium bromide can be decreased when combined with Atomoxetine.
Iproniazid
Iproniazid may increase the central neurotoxic activities of Atomoxetine.
Irinotecan
The metabolism of Irinotecan can be decreased when combined with Atomoxetine.
Isavuconazole
The metabolism of Isavuconazole can be decreased when combined with Atomoxetine.
Isavuconazonium
The metabolism of Isavuconazonium can be decreased when combined with Atomoxetine.
Isocarboxazid
Isocarboxazid may increase the central neurotoxic activities of Atomoxetine.
Isoetharine
Atomoxetine may increase the tachycardic activities of Isoetarine.
Isoniazid
The metabolism of Atomoxetine can be decreased when combined with Isoniazid.
Isoproterenol
Atomoxetine may increase the hypertensive activities of Isoprenaline.
Isosorbide Dinitrate
The metabolism of Isosorbide Dinitrate can be decreased when combined with Atomoxetine.
Isosorbide Mononitrate
The metabolism of Isosorbide Mononitrate can be decreased when combined with Atomoxetine.
Isoxsuprine
Atomoxetine may increase the hypertensive activities of Isoxsuprine.
Isradipine
The metabolism of Isradipine can be decreased when combined with Atomoxetine.
Itraconazole
The metabolism of Itraconazole can be decreased when combined with Atomoxetine.
Ivabradine
The serum concentration of Ivabradine can be increased when it is combined with Atomoxetine.
Ivacaftor
The serum concentration of Ivacaftor can be increased when it is combined with Atomoxetine.
Ivermectin
The metabolism of Ivermectin can be decreased when combined with Atomoxetine.
Ixabepilone
The metabolism of Ixabepilone can be decreased when combined with Atomoxetine.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Atomoxetine.
Ketamine
The metabolism of Ketamine can be decreased when combined with Atomoxetine.
Ketazolam
The metabolism of Ketazolam can be decreased when combined with Atomoxetine.
Ketoconazole
The metabolism of Ketoconazole can be decreased when combined with Atomoxetine.
Labetalol
Atomoxetine may increase the hypertensive activities of Labetalol.
Lacidipine
The metabolism of Lacidipine can be decreased when combined with Atomoxetine.
Lansoprazole
The metabolism of Lansoprazole can be decreased when combined with Atomoxetine.
Lapatinib
The metabolism of Lapatinib can be decreased when combined with Atomoxetine.
Lenvatinib
The metabolism of Lenvatinib can be decreased when combined with Atomoxetine.
Lenvatinib Mesylate
The metabolism of Lenvatinib can be decreased when combined with Atomoxetine.
Lercanidipine
The metabolism of Lercanidipine can be decreased when combined with Atomoxetine.
Letermovir
The metabolism of Letermovir can be decreased when combined with Atomoxetine.
Letrozole
The metabolism of Letrozole can be decreased when combined with Atomoxetine.
Leuprolide
Atomoxetine may increase the QTc-prolonging activities of Leuprolide.
Levalbuterol
Atomoxetine may increase the tachycardic activities of Levosalbutamol.
Levobupivacaine
The metabolism of Levobupivacaine can be decreased when combined with Atomoxetine.
Levocetirizine
The metabolism of Levocetirizine can be decreased when combined with Atomoxetine.
Levodopa
The metabolism of Levodopa can be decreased when combined with Atomoxetine.
Levofloxacin
Atomoxetine may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Atomoxetine may increase the QTc-prolonging activities of Levofloxacin.
Levomethadyl
The metabolism of Levomethadyl Acetate can be decreased when combined with Atomoxetine.
Levomilnacipran
The metabolism of Levomilnacipran can be decreased when combined with Atomoxetine.
Levonorgestrel
The metabolism of Levonorgestrel can be decreased when combined with Atomoxetine.
Levothyroxine
The metabolism of Levothyroxine can be decreased when combined with Atomoxetine.
Lidocaine
The metabolism of Lidocaine can be decreased when combined with Atomoxetine.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Atomoxetine.
Lomitapide
The serum concentration of Lomitapide can be increased when it is combined with Atomoxetine.
Lomustine
The metabolism of Lomustine can be decreased when combined with Atomoxetine.
Loperamide
The metabolism of Loperamide can be decreased when combined with Atomoxetine.
Lopinavir
The serum concentration of Atomoxetine can be increased when it is combined with Lopinavir.
Loratadine
The metabolism of Loratadine can be decreased when combined with Atomoxetine.
Lorcaserin
The metabolism of Lorcaserin can be decreased when combined with Atomoxetine.
Losartan
The metabolism of Losartan can be decreased when combined with Atomoxetine.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Atomoxetine.
Luliconazole
The serum concentration of Atomoxetine can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Atomoxetine can be decreased when it is combined with Lumacaftor.
Lumefantrine
Atomoxetine may increase the QTc-prolonging activities of Lumefantrine.
Lurasidone
The serum concentration of Lurasidone can be increased when it is combined with Atomoxetine.
Macimorelin
The metabolism of Macimorelin can be decreased when combined with Atomoxetine.
Macitentan
The metabolism of Macitentan can be decreased when combined with Atomoxetine.
Manidipine
The metabolism of Atomoxetine can be decreased when combined with Manidipine.
Maprotiline
The metabolism of Maprotiline can be decreased when combined with Atomoxetine.
Maraviroc
The metabolism of Maraviroc can be decreased when combined with Atomoxetine.
Mebendazole
The metabolism of Mebendazole can be decreased when combined with Atomoxetine.
Medroxyprogesterone Acetate
The metabolism of Medroxyprogesterone acetate can be decreased when combined with Atomoxetine.
Mefloquine
The metabolism of Mefloquine can be decreased when combined with Atomoxetine.
Meloxicam
The metabolism of Meloxicam can be decreased when combined with Atomoxetine.
Meperidine
The metabolism of Pethidine can be decreased when combined with Atomoxetine.
Mephentermine
Atomoxetine may increase the hypertensive activities of Mephentermine.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Atomoxetine.
Mequitazine
The metabolism of Mequitazine can be decreased when combined with Atomoxetine.
Mesoridazine
The metabolism of Mesoridazine can be decreased when combined with Atomoxetine.
Metaproterenol
Atomoxetine may increase the hypertensive activities of Orciprenaline.
Metaraminol
Atomoxetine may increase the hypertensive activities of Metaraminol.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Atomoxetine.
Methadone
The metabolism of Methadone can be decreased when combined with Atomoxetine.
Methamphetamine
Atomoxetine may increase the hypertensive activities of Methamphetamine.
Methaqualone
The metabolism of Methaqualone can be decreased when combined with Atomoxetine.
Methotrimeprazine
The serum concentration of Atomoxetine can be increased when it is combined with Methotrimeprazine.
Methoxamine
Atomoxetine may increase the hypertensive activities of Methoxamine.
Methoxsalen
The metabolism of Methoxsalen can be decreased when combined with Atomoxetine.
Methoxyflurane
The metabolism of Methoxyflurane can be decreased when combined with Atomoxetine.
Methylene blue
Methylene blue may increase the central neurotoxic activities of Atomoxetine.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Atomoxetine.
Methylphenidate
The metabolism of Methylphenidate can be decreased when combined with Atomoxetine.
Methylprednisolone
The metabolism of Methylprednisolone can be decreased when combined with Atomoxetine.
Methyltestosterone
The metabolism of Methyltestosterone can be decreased when combined with Atomoxetine.
Methyprylon
The metabolism of Methyprylon can be decreased when combined with Atomoxetine.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Atomoxetine.
Metoclopramide
The metabolism of Metoclopramide can be decreased when combined with Atomoxetine.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Atomoxetine.
Metronidazole
The metabolism of Metronidazole can be decreased when combined with Atomoxetine.
Mexiletine
The metabolism of Mexiletine can be decreased when combined with Atomoxetine.
Mianserin
The metabolism of Mianserin can be decreased when combined with Atomoxetine.
Mibefradil
The metabolism of Mibefradil can be decreased when combined with Atomoxetine.
Miconazole
The metabolism of Miconazole can be decreased when combined with Atomoxetine.
Midazolam
The metabolism of Midazolam can be decreased when combined with Atomoxetine.
Midodrine
Atomoxetine may increase the hypertensive activities of Midodrine.
Midostaurin
The serum concentration of Atomoxetine can be increased when it is combined with Midostaurin.
Mifepristone
Mifepristone may increase the QTc-prolonging activities of Atomoxetine.
Minaprine
Minaprine may increase the central neurotoxic activities of Atomoxetine.
Mirabegron
The metabolism of Mirabegron can be decreased when combined with Atomoxetine.
Mirtazapine
The metabolism of Mirtazapine can be decreased when combined with Atomoxetine.
Moclobemide
Moclobemide may increase the central neurotoxic activities of Atomoxetine.
Modafinil
The metabolism of Modafinil can be decreased when combined with Atomoxetine.
Montelukast
The metabolism of Montelukast can be decreased when combined with Atomoxetine.
Morphine
The metabolism of Morphine can be decreased when combined with Atomoxetine.
Moxifloxacin
Atomoxetine may increase the QTc-prolonging activities of Moxifloxacin.
Mycophenolate Mofetil
The metabolism of Mycophenolate mofetil can be decreased when combined with Atomoxetine.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Atomoxetine.
Naloxone
The metabolism of Naloxone can be decreased when combined with Atomoxetine.
Nateglinide
The metabolism of Nateglinide can be decreased when combined with Atomoxetine.
Nebivolol
The serum concentration of Nebivolol can be increased when it is combined with Atomoxetine.
Nefazodone
The metabolism of Nefazodone can be decreased when combined with Atomoxetine.
Nelfinavir
The metabolism of Nelfinavir can be decreased when combined with Atomoxetine.
Neratinib
The metabolism of Neratinib can be decreased when combined with Atomoxetine.
Netupitant
The metabolism of Netupitant can be decreased when combined with Atomoxetine.
Nevirapine
The metabolism of Nevirapine can be decreased when combined with Atomoxetine.
Nialamide
Nialamide may increase the central neurotoxic activities of Atomoxetine.
Nicardipine
The metabolism of Nicardipine can be decreased when combined with Atomoxetine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Atomoxetine.
Nicotine
The metabolism of Nicotine can be decreased when combined with Atomoxetine.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Atomoxetine.
Nifedipine
The metabolism of Nifedipine can be decreased when combined with Atomoxetine.
Nilotinib
Atomoxetine may increase the QTc-prolonging activities of Nilotinib.
Nilvadipine
The metabolism of Nilvadipine can be decreased when combined with Atomoxetine.
Nimodipine
The serum concentration of Nimodipine can be increased when it is combined with Atomoxetine.
Nisoldipine
The metabolism of Nisoldipine can be decreased when combined with Atomoxetine.
Nitrazepam
The metabolism of Nitrazepam can be decreased when combined with Atomoxetine.
Nitrendipine
The metabolism of Nitrendipine can be decreased when combined with Atomoxetine.
Nitrofurazone
The metabolism of Nitrofural can be decreased when combined with Atomoxetine.
Norepinephrine
Atomoxetine may increase the hypertensive activities of Norepinephrine.
Norethindrone
The metabolism of Norethisterone can be decreased when combined with Atomoxetine.
Norgestrel
The metabolism of Norgestrel can be decreased when combined with Atomoxetine.
Nortriptyline
The metabolism of Nortriptyline can be decreased when combined with Atomoxetine.
Nylidrin
Atomoxetine may increase the hypertensive activities of Nylidrin.
Ofloxacin
Atomoxetine may increase the QTc-prolonging activities of Ofloxacin.
Olanzapine
The metabolism of Olanzapine can be decreased when combined with Atomoxetine.
Olaparib
The serum concentration of Olaparib can be increased when it is combined with Atomoxetine.
Olodaterol
Atomoxetine may increase the tachycardic activities of Olodaterol.
Olopatadine
The metabolism of Olopatadine can be decreased when combined with Atomoxetine.
Omeprazole
The metabolism of Omeprazole can be decreased when combined with Atomoxetine.
Ondansetron
The metabolism of Ondansetron can be decreased when combined with Atomoxetine.
Opium
The metabolism of Opium can be decreased when combined with Atomoxetine.
Orphenadrine
The metabolism of Orphenadrine can be decreased when combined with Atomoxetine.
Ospemifene
The metabolism of Ospemifene can be decreased when combined with Atomoxetine.
Oxazepam
The metabolism of Oxazepam can be decreased when combined with Atomoxetine.
Oxybutynin
The metabolism of Oxybutynin can be decreased when combined with Atomoxetine.
Oxycodone
The risk or severity of adverse effects can be increased when Atomoxetine is combined with Oxycodone.
Oxymetazoline
Atomoxetine may increase the hypertensive activities of Oxymetazoline.
Oxymorphone
The metabolism of Oxymorphone can be decreased when combined with Atomoxetine.
p-Hydroxyamphetamine
Atomoxetine may increase the hypertensive activities of Hydroxyamphetamine.
Paclitaxel
The metabolism of Paclitaxel can be decreased when combined with Atomoxetine.
Palbociclib
The metabolism of Palbociclib can be decreased when combined with Atomoxetine.
Paliperidone
Atomoxetine may increase the QTc-prolonging activities of Paliperidone.
Palonosetron
The metabolism of Palonosetron can be decreased when combined with Atomoxetine.
Panobinostat
The serum concentration of Atomoxetine can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Pantoprazole can be decreased when combined with Atomoxetine.
Paramethadione
The metabolism of Paramethadione can be decreased when combined with Atomoxetine.
Paramethasone
The metabolism of Paramethasone can be decreased when combined with Atomoxetine.
Parecoxib
The metabolism of Parecoxib can be decreased when combined with Atomoxetine.
Paregoric
The metabolism of Morphine can be decreased when combined with Atomoxetine.
Pargyline
Pargyline may increase the central neurotoxic activities of Atomoxetine.
Paricalcitol
The metabolism of Paricalcitol can be decreased when combined with Atomoxetine.
Paritaprevir
The metabolism of Paritaprevir can be decreased when combined with Atomoxetine.
Paroxetine
The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.
Pazopanib
The metabolism of Pazopanib can be decreased when combined with Atomoxetine.
Peginterferon Alfa-2b
The serum concentration of Atomoxetine can be decreased when it is combined with Peginterferon alfa-2b.
Pentamidine
The metabolism of Pentamidine can be decreased when combined with Atomoxetine.
Perampanel
The metabolism of Perampanel can be decreased when combined with Atomoxetine.
Perflutren
Atomoxetine may increase the QTc-prolonging activities of Perflutren.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Atomoxetine.
Perhexiline
The metabolism of Perhexiline can be decreased when combined with Atomoxetine.
Permethrin
The metabolism of Permethrin can be decreased when combined with Atomoxetine.
Perphenazine
The metabolism of Perphenazine can be decreased when combined with Atomoxetine.
Phenacetin
The metabolism of Phenacetin can be decreased when combined with Atomoxetine.
Phenelzine
Phenelzine may increase the central neurotoxic activities of Atomoxetine.
Phenformin
The metabolism of Phenformin can be decreased when combined with Atomoxetine.
Phenmetrazine
Atomoxetine may increase the hypertensive activities of Phenmetrazine.
Phenoxybenzamine
The metabolism of Phenoxybenzamine can be decreased when combined with Atomoxetine.
Phenprocoumon
The metabolism of Phenprocoumon can be decreased when combined with Atomoxetine.
Phentermine
Atomoxetine may increase the hypertensive activities of Phentermine.
PHENTERMINE RESIN
Atomoxetine may increase the hypertensive activities of Phentermine.
Phenylephrine
Atomoxetine may increase the hypertensive activities of Phenylephrine.
Phenylpropanolamine
Atomoxetine may increase the hypertensive activities of Phenylpropanolamine.
Phenytoin
The metabolism of Atomoxetine can be increased when combined with Phenytoin.
Pilocarpine
The metabolism of Pilocarpine can be decreased when combined with Atomoxetine.
Pimecrolimus
The metabolism of Pimecrolimus can be decreased when combined with Atomoxetine.
Pimozide
The serum concentration of Pimozide can be increased when it is combined with Atomoxetine.
Pinacidil
The metabolism of Pinacidil can be decreased when combined with Atomoxetine.
Pindolol
The metabolism of Pindolol can be decreased when combined with Atomoxetine.
Pioglitazone
The metabolism of Pioglitazone can be decreased when combined with Atomoxetine.
Piperazine
The metabolism of Piperazine can be decreased when combined with Atomoxetine.
Pipothiazine
The metabolism of Pipotiazine can be decreased when combined with Atomoxetine.
Pirbuterol
Atomoxetine may increase the tachycardic activities of Pirbuterol.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Atomoxetine.
Podofilox
The metabolism of Podofilox can be decreased when combined with Atomoxetine.
Pomalidomide
The metabolism of Pomalidomide can be decreased when combined with Atomoxetine.
Ponatinib
The metabolism of Ponatinib can be decreased when combined with Atomoxetine.
Posaconazole
The metabolism of Posaconazole can be decreased when combined with Atomoxetine.
Prasterone
The metabolism of Prasterone can be decreased when combined with Atomoxetine.
Prasugrel
The metabolism of Prasugrel can be decreased when combined with Atomoxetine.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Atomoxetine.
Prazepam
The metabolism of Prazepam can be decreased when combined with Atomoxetine.
Praziquantel
The metabolism of Praziquantel can be decreased when combined with Atomoxetine.
Prednisolone
The metabolism of Prednisolone can be decreased when combined with Atomoxetine.
Prednisone
The metabolism of Prednisone can be decreased when combined with Atomoxetine.
Primaquine
The metabolism of Primaquine can be decreased when combined with Atomoxetine.
Procainamide
Atomoxetine may increase the QTc-prolonging activities of Procainamide.
Procarbazine
Procarbazine may increase the central neurotoxic activities of Atomoxetine.
Procaterol
Atomoxetine may increase the hypertensive activities of Procaterol.
Prochlorperazine
The metabolism of Prochlorperazine can be decreased when combined with Atomoxetine.
Progesterone
The metabolism of Progesterone can be decreased when combined with Atomoxetine.
Proguanil
The metabolism of Proguanil can be decreased when combined with Atomoxetine.
Promazine
The metabolism of Promazine can be decreased when combined with Atomoxetine.
Promethazine
The metabolism of Promethazine can be decreased when combined with Atomoxetine.
Propafenone
The serum concentration of Atomoxetine can be increased when it is combined with Propafenone.
Propofol
The metabolism of Propofol can be decreased when combined with Atomoxetine.
Propoxyphene
The metabolism of Dextropropoxyphene can be decreased when combined with Atomoxetine.
Propoxyphene Napsylate
The metabolism of Propoxyphene napsylate can be decreased when combined with Atomoxetine.
Propranolol
The metabolism of Propranolol can be decreased when combined with Atomoxetine.
Protriptyline
The metabolism of Protriptyline can be decreased when combined with Atomoxetine.
Pseudoephedrine
Atomoxetine may increase the hypertensive activities of Pseudoephedrine.
Pyrazinamide
The metabolism of Pyrazinamide can be decreased when combined with Atomoxetine.
Quazepam
The metabolism of Quazepam can be decreased when combined with Atomoxetine.
Quetiapine
Atomoxetine may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Atomoxetine may increase the QTc-prolonging activities of Quetiapine.
Quinacrine
The metabolism of Quinacrine can be decreased when combined with Atomoxetine.
Quinidine
The serum concentration of Atomoxetine can be increased when it is combined with Quinidine.
Quinine
Atomoxetine may increase the QTc-prolonging activities of Quinine.
Rabeprazole
The metabolism of Rabeprazole can be decreased when combined with Atomoxetine.
Racepinephrine
Atomoxetine may increase the hypertensive activities of Racepinephrine.
Raloxifene
The metabolism of Raloxifene can be decreased when combined with Atomoxetine.
Ramelteon
The metabolism of Ramelteon can be decreased when combined with Atomoxetine.
Ranitidine
The metabolism of Ranitidine can be decreased when combined with Atomoxetine.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Atomoxetine.
Rasagiline
Rasagiline may increase the central neurotoxic activities of Atomoxetine.
Reboxetine
The metabolism of Reboxetine can be decreased when combined with Atomoxetine.
Regorafenib
The metabolism of Regorafenib can be decreased when combined with Atomoxetine.
Remoxipride
The metabolism of Remoxipride can be decreased when combined with Atomoxetine.
Repaglinide
The metabolism of Repaglinide can be decreased when combined with Atomoxetine.
Retapamulin
The metabolism of Retapamulin can be decreased when combined with Atomoxetine.
Rifabutin
The metabolism of Rifabutin can be decreased when combined with Atomoxetine.
Rifampin
The metabolism of Atomoxetine can be increased when combined with Rifampicin.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Atomoxetine.
Riociguat
The metabolism of Riociguat can be decreased when combined with Atomoxetine.
Risperidone
The metabolism of Risperidone can be decreased when combined with Atomoxetine.
Ritodrine
Atomoxetine may increase the hypertensive activities of Ritodrine.
Ritonavir
The serum concentration of Atomoxetine can be increased when it is combined with Ritonavir.
Rivaroxaban
The metabolism of Rivaroxaban can be decreased when combined with Atomoxetine.
Rofecoxib
The metabolism of Rofecoxib can be decreased when combined with Atomoxetine.
Rolapitant
The metabolism of Rolapitant can be decreased when combined with Atomoxetine.
Romidepsin
The metabolism of Romidepsin can be decreased when combined with Atomoxetine.
Ropinirole
The metabolism of Ropinirole can be decreased when combined with Atomoxetine.
Ropivacaine
The metabolism of Ropivacaine can be decreased when combined with Atomoxetine.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Atomoxetine.
Rotigotine
The metabolism of Rotigotine can be decreased when combined with Atomoxetine.
Roxithromycin
The metabolism of Roxithromycin can be decreased when combined with Atomoxetine.
Rucaparib
The metabolism of Rucaparib can be decreased when combined with Atomoxetine.
Ruxolitinib
The metabolism of Ruxolitinib can be decreased when combined with Atomoxetine.
Safinamide
The metabolism of Safinamide can be decreased when combined with Atomoxetine.
Salmeterol
The serum concentration of Salmeterol can be increased when it is combined with Atomoxetine.
Saquinavir
The metabolism of Saquinavir can be decreased when combined with Atomoxetine.
Saquinavir Mesylate
The metabolism of Saquinavir can be decreased when combined with Atomoxetine.
Saxagliptin
The serum concentration of Saxagliptin can be increased when it is combined with Atomoxetine.
Saxagliptin Anhydrous
The serum concentration of Saxagliptin can be increased when it is combined with Atomoxetine.
Selegiline
Selegiline may increase the central neurotoxic activities of Atomoxetine.
Selexipag
The metabolism of Selexipag can be decreased when combined with Atomoxetine.
Sertindole
The metabolism of Sertindole can be decreased when combined with Atomoxetine.
Sertraline
The metabolism of Sertraline can be decreased when combined with Atomoxetine.
Sevoflurane
The metabolism of Sevoflurane can be decreased when combined with Atomoxetine.
Sibutramine
The metabolism of Sibutramine can be decreased when combined with Atomoxetine.
Sildenafil
The metabolism of Sildenafil can be decreased when combined with Atomoxetine.
Silodosin
The metabolism of Silodosin can be decreased when combined with Atomoxetine.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Atomoxetine.
Sirolimus
The metabolism of Sirolimus can be decreased when combined with Atomoxetine.
Sitagliptin
The metabolism of Sitagliptin can be decreased when combined with Atomoxetine.
Sitagliptin Phosphate
The metabolism of Sitagliptin can be decreased when combined with Atomoxetine.
Solifenacin
The metabolism of Solifenacin can be decreased when combined with Atomoxetine.
Sonidegib
The serum concentration of Sonidegib can be increased when it is combined with Atomoxetine.
Sorafenib
The metabolism of Sorafenib can be decreased when combined with Atomoxetine.
Sotalol
Atomoxetine may increase the QTc-prolonging activities of Sotalol.
Spiramycin
The metabolism of Spiramycin can be decreased when combined with Atomoxetine.
Sufentanil
The metabolism of Sufentanil can be decreased when combined with Atomoxetine.
Sulfadiazine
The metabolism of Sulfadiazine can be decreased when combined with Atomoxetine.
Sulfamethoxazole
The metabolism of Sulfamethoxazole can be decreased when combined with Atomoxetine.
Sulfinpyrazone
The metabolism of Sulfinpyrazone can be decreased when combined with Atomoxetine.
Sulfisoxazole
Atomoxetine may increase the QTc-prolonging activities of Sulfisoxazole.
Sunitinib
The metabolism of Sunitinib can be decreased when combined with Atomoxetine.
Suvorexant
The serum concentration of Suvorexant can be increased when it is combined with Atomoxetine.
Synephrine
Atomoxetine may increase the hypertensive activities of Synephrine.
synthetic conjugated estrogens, A
The metabolism of Synthetic Conjugated Estrogens, A can be decreased when combined with Atomoxetine.
synthetic conjugated estrogens, B
The metabolism of Synthetic Conjugated Estrogens, B can be decreased when combined with Atomoxetine.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Atomoxetine.
Tadalafil
The metabolism of Tadalafil can be decreased when combined with Atomoxetine.
Tamoxifen
The serum concentration of the active metabolites of Tamoxifen can be reduced when Tamoxifen is used in combination with Atomoxetine resulting in a loss in efficacy.
Tamsulosin
The metabolism of Tamsulosin can be decreased when combined with Atomoxetine.
Tapentadol
The metabolism of Tapentadol can be decreased when combined with Atomoxetine.
Tegaserod
The metabolism of Tegaserod can be decreased when combined with Atomoxetine.
Telaprevir
The metabolism of Telaprevir can be decreased when combined with Atomoxetine.
Telavancin
Atomoxetine may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The metabolism of Telithromycin can be decreased when combined with Atomoxetine.
Temazepam
The metabolism of Temazepam can be decreased when combined with Atomoxetine.
Temsirolimus
The metabolism of Temsirolimus can be decreased when combined with Atomoxetine.
Teniposide
The metabolism of Teniposide can be decreased when combined with Atomoxetine.
Terbinafine
The serum concentration of Atomoxetine can be increased when it is combined with Terbinafine.
Terbutaline
Atomoxetine may increase the hypertensive activities of Terbutaline.
Terbutaline Sulfate
Atomoxetine may increase the hypertensive activities of Terbutaline.
Terfenadine
The metabolism of Terfenadine can be decreased when combined with Atomoxetine.
Testosterone
The metabolism of Testosterone can be decreased when combined with Atomoxetine.
Testosterone Cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Atomoxetine.
Testosterone Enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Atomoxetine.
Testosterone Propionate
The metabolism of Testosterone propionate can be decreased when combined with Atomoxetine.
Testosterone Undecanoate
The metabolism of Testosterone undecanoate can be decreased when combined with Atomoxetine.
Tetrabenazine
Atomoxetine may increase the QTc-prolonging activities of Tetrabenazine.
Tetracycline
The metabolism of Tetracycline can be decreased when combined with Atomoxetine.
Tetrahydrocannabinol
The serum concentration of Dronabinol can be increased when it is combined with Atomoxetine.
Tetrahydrozoline
Atomoxetine may increase the hypertensive activities of Tetryzoline.
Tezacaftor
The metabolism of Tezacaftor can be decreased when combined with Atomoxetine.
Theophylline
The metabolism of Theophylline can be decreased when combined with Atomoxetine.
Theophylline anhydrous
The metabolism of Theophylline can be decreased when combined with Atomoxetine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Atomoxetine.
Thiotepa
The metabolism of Thiotepa can be decreased when combined with Atomoxetine.
Tiagabine
The metabolism of Tiagabine can be decreased when combined with Atomoxetine.
Ticagrelor
The metabolism of Ticagrelor can be decreased when combined with Atomoxetine.
Ticlopidine
The metabolism of Atomoxetine can be decreased when combined with Ticlopidine.
Timolol
The metabolism of Timolol can be decreased when combined with Atomoxetine.
Timolol Anhydrous
The metabolism of Timolol can be decreased when combined with Atomoxetine.
Tinidazole
The metabolism of Tinidazole can be decreased when combined with Atomoxetine.
Tiotropium
The metabolism of Tiotropium can be decreased when combined with Atomoxetine.
Tipranavir
The serum concentration of Atomoxetine can be increased when it is combined with Tipranavir.
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Atomoxetine.
Toloxatone
Toloxatone may increase the central neurotoxic activities of Atomoxetine.
Tolterodine
The metabolism of Tolterodine can be decreased when combined with Atomoxetine.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Atomoxetine.
Topiramate
The metabolism of Atomoxetine can be decreased when combined with Topiramate.
Toremifene
Atomoxetine may increase the QTc-prolonging activities of Toremifene.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Atomoxetine.
Tramadol
The therapeutic efficacy of Tramadol can be decreased when used in combination with Atomoxetine.
Tramazoline
Atomoxetine may increase the hypertensive activities of Tramazoline.
Tranylcypromine
Tranylcypromine may increase the central neurotoxic activities of Atomoxetine.
Trazodone
The metabolism of Trazodone can be decreased when combined with Atomoxetine.
Tretinoin
The metabolism of Tretinoin can be decreased when combined with Atomoxetine.
Triamcinolone
The metabolism of Triamcinolone can be decreased when combined with Atomoxetine.
Triazolam
The metabolism of Triazolam can be decreased when combined with Atomoxetine.
Trimethadione
The metabolism of Trimethadione can be decreased when combined with Atomoxetine.
Trimethoprim
The metabolism of Trimethoprim can be decreased when combined with Atomoxetine.
Trimipramine
The metabolism of Trimipramine can be decreased when combined with Atomoxetine.
Troglitazone
The metabolism of Troglitazone can be decreased when combined with Atomoxetine.
Troleandomycin
The metabolism of Troleandomycin can be decreased when combined with Atomoxetine.
Tyramine
Atomoxetine may increase the hypertensive activities of Tyramine.
Ulipristal
The serum concentration of Ulipristal can be increased when it is combined with Atomoxetine.
Umeclidinium
The metabolism of Umeclidinium can be decreased when combined with Atomoxetine.
Valbenazine
The metabolism of Valbenazine can be decreased when combined with Atomoxetine.
Valdecoxib
The metabolism of Valdecoxib can be decreased when combined with Atomoxetine.
Vandetanib
Atomoxetine may increase the QTc-prolonging activities of Vandetanib.
Vardenafil
The metabolism of Vardenafil can be decreased when combined with Atomoxetine.
Velpatasvir
The metabolism of Velpatasvir can be decreased when combined with Atomoxetine.
Vemurafenib
Atomoxetine may increase the QTc-prolonging activities of Vemurafenib.
Venetoclax
The metabolism of Venetoclax can be decreased when combined with Atomoxetine.
Venlafaxine
The metabolism of Venlafaxine can be decreased when combined with Atomoxetine.
Verapamil
The metabolism of Verapamil can be decreased when combined with Atomoxetine.
Vilanterol
Atomoxetine may increase the tachycardic activities of Vilanterol.
Vilazodone
The serum concentration of Vilazodone can be increased when it is combined with Atomoxetine.
Vinblastine
The metabolism of Vinblastine can be decreased when combined with Atomoxetine.
Vincristine
The metabolism of Vincristine can be decreased when combined with Atomoxetine.
Vindesine
The serum concentration of Vindesine can be increased when it is combined with Atomoxetine.
Vinorelbine
The metabolism of Vinorelbine can be decreased when combined with Atomoxetine.
Vismodegib
The metabolism of Vismodegib can be decreased when combined with Atomoxetine.
Voriconazole
The metabolism of Voriconazole can be decreased when combined with Atomoxetine.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Atomoxetine.
Voxilaprevir
The metabolism of Voxilaprevir can be decreased when combined with Atomoxetine.
Warfarin
The metabolism of Warfarin can be decreased when combined with Atomoxetine.
Yohimbine
The metabolism of Yohimbine can be decreased when combined with Atomoxetine.
Zafirlukast
The metabolism of Zafirlukast can be decreased when combined with Atomoxetine.
Zalcitabine
The metabolism of Zalcitabine can be decreased when combined with Atomoxetine.
Zaleplon
The metabolism of Zaleplon can be decreased when combined with Atomoxetine.
Zidovudine
The metabolism of Zidovudine can be decreased when combined with Atomoxetine.
Zileuton
The metabolism of Zileuton can be decreased when combined with Atomoxetine.
Ziprasidone
Atomoxetine may increase the QTc-prolonging activities of Ziprasidone.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Atomoxetine.
Zomepirac
The metabolism of Zomepirac can be decreased when combined with Atomoxetine.
Zonisamide
The metabolism of Zonisamide can be decreased when combined with Atomoxetine.
Zopiclone
The serum concentration of Zopiclone can be increased when it is combined with Atomoxetine.
Zotepine
The metabolism of Zotepine can be decreased when combined with Atomoxetine.
Zuclopenthixol
The serum concentration of Zuclopenthixol can be increased when it is combined with Atomoxetine.
